87/100BAlphabet stock forecast 2026–2030What is an analyst price target? A price target is the price an analyst expects a stock to reach in 12 months. Arincen shows the average, high and low targets and the upside to the average.
Analysts' average 12-month price target for Alphabet is 400.32, 36.6% above the current price of 293.01. Their targets range from 325.00 to 485.00.
Of the 34 firms that rated Alphabet in the past 12 months, 29 rate it buy or strong buy, 5 hold and 0 sell or strong sell (each firm at its latest rating): a Strong buy consensus.
Analysts' 1-year price targets range from 325.00 to 485.00, with an average of 400.32.
| Buy | 29 | |
| Hold | 5 | |
| Sell | 0 |
12-month price target
| Highest target | 485.00 |
| Average target | 400.32 |
| Lowest target | 325.00 |
| Current price | 293.01 |
Alphabet price target historyWhat is an analyst price target? A price target is the price an analyst expects a stock to reach in 12 months. Arincen shows the average, high and low targets and the upside to the average.
Have analysts recently raised or lowered their Alphabet price target and rating?
How analysts rate Alphabet, month by monthWhat is the analyst rating? The analyst rating sums up what the analysts covering a stock recommend, from strong buy to strong sell, by the share of them rating it a buy.
29 of 34 firms rate it buy now, against 33 of 40 in December 2025.
Each month: every firm at its latest rating from the 12 months before. Strong buys count as buys, strong sells as sells.
Alphabet analyst upgrades, downgrades and price targets
The latest rating change came on 29 October 2026, when Citizens downgraded Alphabet from Market Outperform to Market Perform. The most recent new target came from Truist Financial on 29 October 2026: 410.00.
| Date | Firm | Rating | Price target | Change | Price then |
|---|---|---|---|---|---|
| 29 Oct 2026 | Truist Financial | Reiterated · Buy | 420.00 → 410.00 | -2.4% | 286.33 |
| 29 Oct 2026 | Bernstein Mark Shmulik | Reiterated · Market Perform | 390.00 → 325.00 | -16.7% | 285.03 |
| 29 Oct 2026 | Wedbush | Reiterated · Outperform | 370.00 → 387.00 | +4.6% | 284.51 |
| 29 Oct 2026 | KeyBanc | Reiterated · Overweight | 410.00 → 385.00 | -6.1% | 324.89 |
| 29 Oct 2026 | Cantor Fitzgerald Deepak Mathivanan | Reiterated · Overweight | 420.00 → 350.00 | -16.7% | 324.89 |
| 29 Oct 2026 | Goldman Sachs Eric Sheridan | — | 450.00 → 385.00 | -14.4% | 324.89 |
| 29 Oct 2026 | UBS | Reiterated · Neutral | 380.00 → 332.00 | -12.6% | 324.89 |
| 29 Oct 2026 | Piper Sandler | Reiterated · Overweight | 445.00 → 345.00 | -22.5% | 324.89 |
| 29 Oct 2026 | MoffettNathanson | — | 345.00 | — | 324.89 |
| 29 Oct 2026 | Citizens | Downgraded · Market Outperform → Market Perform | — | — | — |
| 20 Oct 2026 | BMO Capital Brian Pitz | Reiterated · Outperform | 465.00 → 480.00 | +3.2% | 343.67 |
| 19 Oct 2026 | KeyBanc | Reiterated · Overweight | 425.00 → 410.00 | -3.5% | 343.76 |
| 14 Oct 2026 | UBS | Reiterated · Neutral | 400.00 → 380.00 | -5.0% | 353.78 |
| 6 Oct 2026 | Wells Fargo | Reiterated · Overweight | 411.00 → 417.00 | +1.5% | 346.47 |
| 17 Sept 2026 | Tigress Financial Ivan Feinseth | — | 415.00 → 485.00 | +16.9% | 347.33 |
| 16 Sept 2026 | Evercore ISI Mark Mahaney | — | 400.00 → 450.00 | +12.5% | 342.87 |
| 23 Jul 2026 | D.A. Davidson | — | 300.00 → 350.00 | +16.7% | 316.02 |
| 23 Jul 2026 | BMO Capital Brian Pitz | Reiterated · Outperform | 455.00 → 465.00 | +2.2% | 321.44 |
| 23 Jul 2026 | Roth Capital | Reiterated · Buy | 365.00 → 440.00 | +20.5% | 342.09 |
| 23 Jul 2026 | Truist Financial | Reiterated · Buy | 430.00 → 420.00 | -2.3% | 342.09 |
| 23 Jul 2026 | Cantor Fitzgerald Deepak Mathivanan | Reiterated · Overweight | 370.00 → 420.00 | +13.5% | 342.09 |
| 23 Jul 2026 | Morgan Stanley | Reiterated · Overweight | 415.00 → 400.00 | -3.6% | 342.09 |
| 23 Jul 2026 | Wells Fargo Ken Gawrelski | Reiterated · Overweight | 438.00 → 411.00 | -6.2% | 342.09 |
| 23 Jul 2026 | Barclays | Reiterated · Overweight | 360.00 → 425.00 | +18.1% | 342.09 |
| 23 Jul 2026 | Pivotal Research | Reiterated · Buy | 475.00 | — | 342.09 |
| 21 Jul 2026 | Wells Fargo Ken Gawrelski | Reiterated · Overweight | 416.00 → 438.00 | +5.3% | 351.99 |
| 17 Jul 2026 | BMO Capital | Reiterated · Outperform | 400.00 → 455.00 | +13.7% | 354.46 |
| 13 Jul 2026 | UBS Stephen Ju | Reiterated · Neutral | 435.00 → 400.00 | -8.0% | 355.50 |
| 2 Jul 2026 | Wells Fargo | Reiterated · Overweight | 435.00 → 416.00 | -4.4% | 361.21 |
| 30 Jun 2026 | Morgan Stanley | Reiterated · Overweight | 375.00 → 415.00 | +10.7% | 353.65 |
| 2 Jun 2026 | HSBC Paul Rossington | Reiterated · Buy | 285.00 → 420.00 | +47.4% | 367.74 |
| 1 Jun 2026 | Piper Sandler Thomas Champion | Reiterated · Overweight | 425.00 → 445.00 | +4.7% | 380.34 |
| 29 May 2026 | Truist Financial | Reiterated · Buy | 415.00 → 430.00 | +3.6% | 382.58 |
| 20 May 2026 | Wells Fargo | Reiterated · Overweight | 397.00 → 435.00 | +9.6% | 387.66 |
| 4 May 2026 | Freedom Broker | Downgraded · Buy → Hold | — | — | — |
| 30 Apr 2026 | Morgan Stanley | Reiterated · Overweight | 270.00 → 375.00 | +38.9% | 384.54 |
| 30 Apr 2026 | UBS | Reiterated · Neutral | 410.00 → 435.00 | +6.1% | 372.50 |
| 30 Apr 2026 | Needham Laura Martin | Reiterated · Buy | 400.00 → 450.00 | +12.5% | 373.30 |
| 30 Apr 2026 | RBC Capital | Reiterated · Outperform | 400.00 → 425.00 | +6.3% | 376.66 |
| 30 Apr 2026 | Goldman Sachs | — | 375.00 → 450.00 | +20.0% | 371.06 |
| 30 Apr 2026 | Bernstein | Reiterated · Market Perform | 305.00 → 390.00 | +27.9% | 349.94 |
| 30 Apr 2026 | Susquehanna | Reiterated · Positive | 350.00 → 460.00 | +31.4% | 349.94 |
| 30 Apr 2026 | Truist Financial | Reiterated · Buy | 385.00 → 415.00 | +7.8% | 349.94 |
| 30 Apr 2026 | Canaccord Genuity | Reiterated · Buy | 415.00 → 450.00 | +8.4% | 349.94 |
| 30 Apr 2026 | Piper Sandler | Reiterated · Overweight | 405.00 → 425.00 | +4.9% | 349.94 |
| 30 Apr 2026 | Guggenheim | Reiterated · Buy | 375.00 → 450.00 | +20.0% | 349.94 |
| 30 Apr 2026 | UBS Stephen Ju | — | 375.00 → 410.00 | +9.3% | 349.94 |
| 30 Apr 2026 | KeyBanc | Reiterated · Overweight | 380.00 → 425.00 | +11.8% | 349.94 |
| 30 Apr 2026 | Stifel Nicolaus Mark Kelley | — | 346.00 → 420.00 | +21.4% | 349.94 |
| 30 Apr 2026 | Piper Sandler Ross Sandler | — | 395.00 → 405.00 | +2.5% | 349.94 |
Alphabet EPS and revenue estimatesWhat are estimate revisions? Estimate revisions are the changes analysts make to their EPS and revenue forecasts for the years ahead. They show whether expectations are rising or falling.
Analysts expect Alphabet's EPS to grow 19.0% a year until 2028, slower than over the last 5 years (29.8% a year) and the last 3 years (33.3%).
Analysts expect Alphabet's revenue to grow 24.7% a year until 2028, faster than over the last 5 years (17.2% a year) and the last 3 years (12.5%).
Revenue
EPS
Does Alphabet beat earnings estimates?What is an earnings surprise? An earnings surprise is how far a company's reported EPS or revenue came above or below the analysts' average estimate, in percent.
On average, analysts' EPS estimate was 39.1% off the result, either way, and their revenue estimate 1.8%, over the last 12 quarters.
- EPS beats
- 59 / 89
- Revenue beats
- 59 / 89
- Average EPS surprise, last 12What is an earnings surprise? An earnings surprise is how far a company's reported EPS or revenue came above or below the analysts' average estimate, in percent.
- +34.1%
- Since
- October 2004
| Quarter | Report date | EPS estimate | Reported EPS | Surprise | Revenue estimate | Reported revenue | Surprise |
|---|---|---|---|---|---|---|---|
| Q3 FY2026 | 28 Oct 2026 | 3.02 | 2.12 | -29.8% | 128.00B | 127.58B | -0.3% |
| Q2 FY2026 | 22 Jul 2026 | 2.87 | 9.11 | +217.4% | 116.53B | 119.80B | +2.8% |
| Q1 FY2026 | 29 Apr 2026 | 2.64 | 5.11 | +93.6% | 106.98B | 109.90B | +2.7% |
| Q4 FY2025 | 4 Feb 2026 | 2.57 | 2.82 | +9.7% | 111.33B | 113.83B | +2.2% |
| Q3 FY2025 | 29 Oct 2025 | 2.30 | 2.87 | +24.8% | 99.93B | 102.35B | +2.4% |
| Q2 FY2025 | 23 Jul 2025 | 2.15 | 2.31 | +7.4% | 99.83B | 96.43B | -3.4% |
| Q1 FY2025 | 24 Apr 2025 | 2.02 | 2.81 | +39.1% | 89.15B | 90.23B | +1.2% |
| Q4 FY2024 | 4 Feb 2025 | 2.12 | 2.15 | +1.4% | 96.67B | 96.47B | -0.2% |
| Q3 FY2024 | 29 Oct 2024 | 1.85 | 2.12 | +14.6% | 86.30B | 88.27B | +2.3% |
| Q2 FY2024 | 23 Jul 2024 | 1.84 | 1.89 | +2.7% | 84.19B | 84.74B | +0.7% |
| Q1 FY2024 | 25 Apr 2024 | 1.51 | 1.89 | +25.2% | 78.61B | 80.54B | +2.5% |
| Q4 FY2023 | 30 Jan 2024 | 1.59 | 1.64 | +3.1% | 85.31B | 86.31B | +1.2% |
Alphabet stock price 2026–2030: scenariosHow are the stock price scenarios calculated? Bear, base and bull prices for the years ahead: the analysts' EPS estimates times the lowest, average and highest P/E of the stock today and at its last five year ends, or of its peers.
If Alphabet's earnings grow at the 19.0% a year analysts expect to FY2028, then 15.0% a year, it would earn about 24.09 a share in FY2030. At the P/E it has traded at over the last five years (15.1 to 28.8) that is 363.98 to 692.79 a share, or 546.72 at its average P/E of 22.7. This is arithmetic on the analysts' estimates, not a prediction.
| Fiscal year | EPS | Bear | Base | Bull |
|---|---|---|---|---|
| FY2026 | 19.65 | 296.89 | 445.95 | 565.10 |
| FY2027 | 15.04 | 227.31 | 341.44 | 432.66 |
| FY2028 | 18.21 | 275.22 | 413.40 | 523.85 |
| FY2029 (extrapolated) | 20.94 | 316.51 | 475.41 | 602.43 |
| FY2030 (extrapolated) | 24.09 | 363.98 | 546.72 | 692.79 |
Each year's EPS is the analysts' consensus to FY2028; the years after grow 15.0% a year (the analysts' growth, at most 15%). Bear, base and bull apply the lowest, average and highest P/E of today and the last five fiscal year ends, leaving out any above 60, the mark of a year of collapsed earnings (15.1, 22.7, 28.8).
Is Alphabet stock undervalued or overvalued?How does Arincen work out a stock's fair value? Fair value is our estimate of a share's price at the P/E the company usually trades at, with a low to high range around it.
Alphabet's P/E of 15.1 is near the bottom of its 5-year range (14.4 to 33.6, median 23.9). Analysts do not expect slower growth than in recent years, so it is cheaper than its usual level. Buyers pay about the usual price for each point of growth: a PEG of 0.8 on expected growth against 0.8 on its median P/E and past five years' growth. At its usual P/E (24.9 × EPS of 10.60), Alphabet's fair value is 263.85; the price, 293.01, is 11.1% above it. The EPS is without 8.79 a share of one-off gains in its other income, which the business does not repeat. Its forward P/E, on the consensus for FY2026, is 14.9.
Fair value is the usual (median) P/E of the last five years times the earnings per share of the last twelve months; the ends of the bar are the same earnings at its lowest and highest P/E of those years (17.6 and 39.8). The price against its P/E range
- Price to earnings ratio (TTM)What is the P/E ratio? The P/E ratio divides a share's price by its earnings per share over the last year: what you pay for each dollar of profit.
- 15.11
- Five-year median P/EWhat is the P/E ratio? The P/E ratio divides a share's price by its earnings per share over the last year: what you pay for each dollar of profit.
- 23.89
- Five-year P/E range
- 14.4 – 33.6
- Forward P/E (FY2026)What is the forward P/E ratio? Forward P/E divides a share's price by the earnings per share analysts expect in the coming year, rather than last year's actual earnings.
- 14.91
- PEG ratioWhat is the PEG ratio? The PEG ratio divides the P/E by the yearly earnings growth analysts expect, to show how much you pay for each point of growth.
- 0.80
- To the average targetWhat is an analyst price target? A price target is the price an analyst expects a stock to reach in 12 months. Arincen shows the average, high and low targets and the upside to the average.
- +36.6%
Most undervalued US stocksHow does Arincen work out a stock's fair value? Fair value is our estimate of a share's price at the P/E the company usually trades at, with a low to high range around it.
| Stock | Price | Fair value | Upside |
|---|---|---|---|
| 376.23 | 747.73561Price 376.23935 | +98.7% | |
| 152.620 | 297.58169Price 152.62471 | +95.0% | |
| 158.390 | 305.52158Price 158.39396 | +92.9% | |
| 241.410 | 464.73205Price 241.41627 | +92.5% | |
| 156.930 | 300.15225Price 156.93375 | +91.3% | |
| 37.540 | 71.4258Price 37.54193 | +90.3% | |
| 217.080 | 405.47304Price 217.08507 | +86.8% |
Furthest below the fair value on each stock's page, updated every day.